Tetrapleura tetraptera spice attenuates high-carbohydrate, high-fat diet-induced obese and type 2 diabetic rats with metabolic syndrome features

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Kuate, Dieudonne ^a,b   Kengne, Anne Pascale Nouemsi ^b   Biapa, Cabral Prosper Nya ^b   Azantsa, Boris Gabin Kingue ^c   Wan Muda, Wan Abdul Manan Bin ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b UNIVERSITY OF DSCHANG   (Cameroon)

^c UNIVERSITY OF BUEA   (Cameroon)

Author keywords

High carbohydrate high fat diet; Inflammation; Metabolic syndrome; Obesity; Tetrapleura tetraptera; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; C REACTIVE PROTEIN; CARBOHYDRATE; GLUCOSE; HYDROETHANOLIC EXTRACT; INSULIN; INTERLEUKIN 6; LEPTIN; METFORMIN; PLANT EXTRACT; POLYPHENOL; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIET INDUCED OBESITY; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; EXPERIMENTAL LIVER INJURY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; SPICE; STEATOSIS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TETRAPLEURA; TETRAPLEURA TETRAPTERA; WEIGHT GAIN; ADVERSE EFFECTS; AFRICAN MEDICINE; ANALYSIS; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; FRUIT; METABOLIC SYNDROME X; OBESITY; PHYTOTHERAPY; PROCEDURES; SPRAGUE DAWLEY RAT;

RATTUS; TETRAPLEURA TETRAPTERA;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; FRUIT; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICINE, AFRICAN TRADITIONAL; METABOLIC SYNDROME X; METFORMIN; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TETRAPLEURA;

EID: 84930213062     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0051-0     Document Type: Article

References (60)

1. International Diabetes Federation (IDF), 2013: IDF Diabetes Atlas, 6th edition 2013, http://www.idf.org/sites/default/files/EN-6E-Atlas-Full-0.pdf.
2. Devalaraja S, Jain S, Yadav H. Exotic fruits as therapeutic complements for diabetes, obesity and metabolic syndrome. Food Res Int. 2011;44:1856-65.
3. Xiao H, Xie G, Wang J, Hou X, Wang X, Wu W, et al. Chicoric acid prevents obesity by attenuating hepatic steatosis, inflammation and oxidative stress in high-fat diet-fed mice. Food Res Int. 2013;54:345-53.
4. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12.
5. Chen F, Xiong H, Wang J, Ding X, Shu G, Mei Z. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats. J Ethnopharmacol. 2013;149(3):729-36.
6. Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchanatham S. Anti-inflammatory and anti-hyperlipidemic effect of Semecarpus anacardium in a High fat diet: STZ-induced Type 2 diabetic rat model. Inflammopharmacology. 2013;21:37-46.
7. Prangthipa P, Surasianga R, Charoensiria R, Leardkamolkarnb V, Komindrc S, Yamborisuta U, et al. Amelioration of hyperglycemia, hyperlipidemia, oxidative stress and inflammation in steptozotocin-induced diabetic rats fed a high fat diet by riceberry supplement. J Funct Foods. 2013;5:195-203.
8. Yang YS, Huang CN, Wang CJ, Lee YJ, Chen ML, Peng CH. Polyphenols of Hibiscus sabdariffa improved diabetic nephropathy via regulating the pathogenic markers and kidney functions of type 2 diabetic rats. J Funct Foods. 2013;5:810-9.
9. Connell BSO. Complementary and integrative medicine: emerging therapies for diabetes, part 2: preface. Diabetes spectr. 2001;14:196-7.
10. Adams GG, Imran S, Wang S, Mohammad A, Kok S, Gray DA, et al. The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines. Food Res Int. 2011;44:862-7.
11. Kuate D, Etoundi BC, Ngondi JL, Oben JE. Effects of Dichrostachys glomerata spice on cardiovascular diseases risk factors in normoglycemic and type 2 diabetic obese volunteers. Food Res Int. 2011;44:1197-202.
12. Kuate D, Etoundi BC, Ngondi JL, Wan Manan WABM, Oben JE. Anti-inflammatory, anthropometric and lipomodulatory effects Dyglomera® (aqueous extract of Dichrostachys glomerata) in obese patients with metabolic syndrome. Funct Foods Health Dis. 2013;3(11):416-27.
13. Mbofung CMF, Gee JM, Knight DJ. Fatty acid profile of some Cameroonian spices. J Sci Food Agric. 1994;66:213-6.
14. Adewunmi CO. Control of snail intermediate hosts in schistosomiasis - a review. Niger J Parasitol. 1993;14:45-51.
15. Ojewole JAO, Adewunmi CO. Anti-inflammatory and hypoglycemic effects of Tetrapleura tetraptera (Taub.) (Fabaceae) fruit aqueous extract in rats. J Ethnopharmacol. 2004;95:177-82.
16. Okokon JE, Udokpoh AE, Antia BS. Antimalaria activity of ethanolic extract of Tetrapleura tetraptera fruit. J Ethnopharmacol. 2007;111:537-40.
17. Akin-Idowu PE, Ibitoye DO, Ademoyegun OT, Adeniyi OT. Chemical Composition of the Dry Fruit of Tetrapleura tetraptera and its Potential Impact on Human Health. J Herbs Spices Med Plants. 2011;17:52-61.
18. Essien EU, Izunwane BC, Aremu CY, Eka OU. Significance for humans of the nutrient contents of the dry fruit of Tetrapleura tetraptera. Plant Foods Hum Nutr. 1994;45(1):47-51.
19. Adesina SK. Studies on a Nigerian herbal anticonvulsant recipe. Int J Crude Drug Res. 1982;20:93-100.
20. Jeszka-Skowrona M, Flaczyk E, Jeszka J, Krejpcio Z, Król E, Buchowski MS. Mulberry leaf extract intake reduces hyperglycaemia in streptozotocin (STZ)-induced diabetic rats fed high-fat diet. J Funct Foods. 2014;8C:9-17.
21. Ngassoum MB, Jirovetz L, Buchbauer G. SPME/GC/MS analysis of headspace aroma compounds of the Cameroonian fruit Tetrapleura tetraptera (Thonn.) Taub. Eur Food Res Technol. 2001;213:18-21.
22. Peng CH, Chyau CC, Chan KC, Chan TH, Wang CJ, Huang CN. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance. J Agric Food Chem. 2011;59:9901-9.
23. Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76 A rodent diet. J Nutr. 1993;123:1939-51.
24. Mathews DR, Hosker JP, Rudenkl AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cells function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
25. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.
26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.
27. Ojewole JA, Adesina SK. Mechanism of the hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera. Planta Med. 1983;49(1):46-50.
28. Amissah F, Fleischer TC, Sawer IK, Woode E. Cardiovascular effects of alcoholic extract of Tetrapleura tetraptera (Taub) fruit in vitro and in anaesthetized rats. Ghana Pharmaceutical J. 2007;32:30-8.
29. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27:699-703.
30. Kovacs P, Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab. 2005;19:625-35.
31. Bosma M, Kersten S, Hesselink MKC, Schrauwen P. Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res. 2012;51:36-49.
32. Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119:10-6.
33. Sharmila BG, Kumar G, Murugesan AG. Antihyperlipidemic effect of Gar-lip, a polyherbal formulation in streptozotocin induced diabetic rats. Food Chem Toxicol. 2009;47:2361-5.
34. Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice. J Ethnopharmacol. 2010;129:299-305.
35. Schaffer JE. Lipotoxicity: When tissues overeat. Curr Opin Lipidol. 2003;14(3):281-7.
36. Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr. 2008;138(10):1866-71.
37. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21:1443-55.
38. Bansal P, Paul P, Mudgal JG, Nayak P, Thomas Pannakal S, Priyadarsini KI, et al. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Exp Toxicol Pathol. 2012;64:651-8.
39. Cvetković T, Mitić B, Lazarević G, Vlahović P, Antić S, Stefanović V. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complications. 2009;23:337-42.
40. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, Uric Acid, and the Etiology of Diabetes and Obesity. Diabetes. 2013;62(10):3307-15.
41. Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One. 2013;8, e57873.
42. Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr. 2009;154:807-13.
43. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010;33:2477-83.
44. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol. 2008;295:1370-5.
45. Jobu K, Yokota J, Yoshioka S, Moriyama H, Murata S, Ohishid M, et al. Effects of Goishi tea on diet-induced obesity in mice. Food Res Int. 2013;54:324-9.
46. Ahima RS. Revisiting leptin's role in obesity and weight loss. J Clin Invest 2008. 2008;118(7):2380-3.
47. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222-31.
48. Hansen D, Dendale P, Beelen M, Jonkers RA, Mullens A, Corluy L, et al. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol. 2010;109:397-404.
49. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2001;52:119-23.
50. Kyriazi E, Tsiotra P, Boutati E, Ikonomidis I, Fountoulaki K, Maratou E, et al. Effects of adiponectin in TNF-α, IL-6, and IL-10 cytokine production from coronary artery disease macrophages. Horm Metab Res. 2011;43(08):537-44.
51. Zheng T, Shu G, Yang Z, Mo S, Zhao Y, Mei Z. Antidiabetic effect of total saponins from Entadaphaseoloides (L.) Merr.in type 2 diabetic rats. J Ethnopharmacol. 2012;139(3):814-21.
52. Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-92.
53. Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets. 2010;11:122-35.
54. Fleischer TC, Komlaga G, Mensah AY, Mensah MLK, Wood E, Sawer IK, et al. Flavonoid constituents of the mature fruit of Tetrapleura tetraptera schum. Et Thonn.). J Food Sci Technol. 2006;26(1):47-53.
55. Cheng ZJ, Kuo SC, Chan SC, Ko FN. Teng CM: antioxidant properties of butein isolated from Dalbergia odorifera. Biochim Biophys Acta. 1998;1392:291-9.
56. Yu SM, Kuo SC. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Br J Pharmacol. 1995;114:1587-94.
57. Aida K, Tawata N, Shindo Onaya T, Sasaki H, Yamaguchi T, Chin M, et al. Isoliquiritigenin: a newaldose reductase inhibitor from Glycyrrhiza radix. Planta Med. 1990;56:254-8.
58. Yamamoto S, Aizu E, Jiang H, Nakadate T, Kiyoto I, Wang JC, et al. The potent antitumor-promoting agent isoliquiritigenin. Carcinogenesis. 1991;12:317-23.
59. Wilcox LJ, Borradaile NM, De Dreu LE, Huff MW. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res. 2001;42:725-34.
60. Ali MM, El Kader MA. The influence of naringenin of the oxidative state of rats with streptozotocin - induced acute hyperglycaemia. Z Naturforsch. 2004;59:726-33.